{"id":84301,"date":"2026-05-17T06:16:09","date_gmt":"2026-05-17T06:16:09","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/84301\/"},"modified":"2026-05-17T06:16:09","modified_gmt":"2026-05-17T06:16:09","slug":"kailera-therapeutics-ipo-competing-with-eli-lilly-and-novo-nordisk-in-glp-1-weight-loss-news-and-statistics","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/84301\/","title":{"rendered":"Kailera Therapeutics IPO: Competing with Eli Lilly and Novo Nordisk in GLP-1 Weight Loss &#8211; News and Statistics"},"content":{"rendered":"<p>\n\t\t\t\t\t\t\t\t\t\t\t\tMay 17, 2026\t\t\t\t\t<\/p>\n<p>Private companies in the biotechnology sector are increasingly entering public markets through <a href=\"https:\/\/www.indexbox.io\/store\/branch\/biopharmaceuticals-biotechnology\/\" target=\"_blank\" rel=\"nofollow noopener\">initial public offerings<\/a>, according to a recent analysis. One of the latest entrants is Kailera Therapeutics (NASDAQ: KLRA), which is positioning itself as a rival to <a href=\"https:\/\/app.indexbox.io\/companies\/profile\/741619\/\" target=\"_blank\" rel=\"noopener nofollow\">Eli Lilly<\/a> and <a href=\"https:\/\/app.indexbox.io\/companies\/profile\/721440\/\" target=\"_blank\" rel=\"noopener nofollow\">Novo Nordisk<\/a> in the obesity treatment space with its weight-loss drug candidates.<\/p>\n<p>Kailera priced its IPO at $16 per share and began trading on April 17 at $26 per share. While the stock price has since cooled, the company&#8217;s pipeline of drug candidates has prompted investor speculation about a potential long-term buying opportunity.<\/p>\n<p>Morgan Stanley research projects the GLP-1 drug market, targeting weight loss, could reach $190 billion by 2035\u2014double the levels seen in 2025. Kailera is developing a weight-loss drug pipeline that includes both injectables and pills, with four candidates in various stages of clinical trials. Its lead candidate, the once-weekly injectable Ribupatide, is currently in phase 3 trials. The company has stated that this drug has the potential to become a category-leading treatment for people living with obesity.<\/p>\n<p>Investing in biotech carries significant risk, particularly for companies with no commercial products on the market. Kailera offers a fresh opportunity due to a relative lack of new biotech offerings in recent years, and it has at least one drug candidate that is further along in clinical trials compared to some other firms. However, there is no guarantee that Ribupatide or any of Kailera&#8217;s other drug candidates will receive regulatory approval. The investment is best suited for aggressive investors who are prepared for potential setbacks and believe the potential rewards may eventually outweigh the risks.<\/p>\n<p>The Motley Fool Stock Advisor analyst team has identified what it considers the 10 best stocks for investors to buy now, and Kailera Therapeutics was not included on that list. As a historical example, the team noted that when <a href=\"https:\/\/app.indexbox.io\/companies\/profile\/3992928\/\" target=\"_blank\" rel=\"noopener nofollow\">Netflix<\/a> made a similar list on December 17, 2004, a $1,000 investment would have grown to $469,293 by the time of the report. Similarly, when <a href=\"https:\/\/app.indexbox.io\/companies\/profile\/742093\/\" target=\"_blank\" rel=\"noopener nofollow\">Nvidia<\/a> was included on April 15, 2005, a $1,000 investment would have reached $1,381,332.<\/p>\n<p>\t\t1. INTRODUCTION<\/p>\n<p class=\"text-secondary fs-6\">Making Data-Driven Decisions to Grow Your Business<\/p>\n<p>\t\t\t\tREPORT DESCRIPTION<br \/>\n\t\t\t\tRESEARCH METHODOLOGY AND THE AI PLATFORM<br \/>\n\t\t\t\tDATA-DRIVEN DECISIONS FOR YOUR BUSINESS<br \/>\n\t\t\t\tGLOSSARY AND SPECIFIC TERMS<\/p>\n<p>\t\t2. EXECUTIVE SUMMARY<\/p>\n<p class=\"text-secondary fs-6\">A Quick Overview of Market Performance<\/p>\n<p>\t\t\t\tKEY FINDINGS<br \/>\n\t\t\t\tMARKET TRENDS <a class=\"px-2\" href=\"https:\/\/www.indexbox.io\/licenses\/\" target=\"_blank\" rel=\"nofollow noopener\">This Chapter is Available Only for the Professional Edition<\/a>PRO<\/p>\n<p>\t\t3. MARKET OVERVIEW<\/p>\n<p class=\"text-secondary fs-6\">Understanding the Current State of The Market and its Prospects<\/p>\n<p>\t\t\t\tMARKET SIZE: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<br \/>\n\t\t\t\tCONSUMPTION BY COUNTRY: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<br \/>\n\t\t\t\tMARKET FORECAST TO 2035<\/p>\n<p>\t\t4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION<\/p>\n<p class=\"text-secondary fs-6\">Finding New Products to Diversify Your Business<\/p>\n<p>\t\t\t\tTOP PRODUCTS TO DIVERSIFY YOUR BUSINESS<br \/>\n\t\t\t\tBEST-SELLING PRODUCTS<br \/>\n\t\t\t\tMOST CONSUMED PRODUCTS<br \/>\n\t\t\t\tMOST TRADED PRODUCTS<br \/>\n\t\t\t\tMOST PROFITABLE PRODUCTS FOR EXPORT<\/p>\n<p>\t\t5. MOST PROMISING SUPPLYING COUNTRIES<\/p>\n<p class=\"text-secondary fs-6\">Choosing the Best Countries to Establish Your Sustainable Supply Chain<\/p>\n<p>\t\t\t\tTOP COUNTRIES TO SOURCE YOUR PRODUCT<br \/>\n\t\t\t\tTOP PRODUCING COUNTRIES<br \/>\n\t\t\t\tTOP EXPORTING COUNTRIES<br \/>\n\t\t\t\tLOW-COST EXPORTING COUNTRIES<\/p>\n<p>\t\t6. MOST PROMISING OVERSEAS MARKETS<\/p>\n<p class=\"text-secondary fs-6\">Choosing the Best Countries to Boost Your Export<\/p>\n<p>\t\t\t\tTOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT<br \/>\n\t\t\t\tTOP CONSUMING MARKETS<br \/>\n\t\t\t\tUNSATURATED MARKETS<br \/>\n\t\t\t\tTOP IMPORTING MARKETS<br \/>\n\t\t\t\tMOST PROFITABLE MARKETS<\/p>\n<p>\t\t7. PRODUCTION<\/p>\n<p class=\"text-secondary fs-6\">The Latest Trends and Insights into The Industry<\/p>\n<p>\t\t\t\tPRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<br \/>\n\t\t\t\tPRODUCTION BY COUNTRY: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<\/p>\n<p>\t\t8. IMPORTS<\/p>\n<p class=\"text-secondary fs-6\">The Largest Import Supplying Countries<\/p>\n<p>\t\t\t\tIMPORTS: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<br \/>\n\t\t\t\tIMPORTS BY COUNTRY: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<br \/>\n\t\t\t\tIMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<\/p>\n<p>\t\t9. EXPORTS<\/p>\n<p class=\"text-secondary fs-6\">The Largest Destinations for Exports<\/p>\n<p>\t\t\t\tEXPORTS: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<br \/>\n\t\t\t\tEXPORTS BY COUNTRY: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<br \/>\n\t\t\t\tEXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012\u20132025) AND FORECAST (2026\u20132035)<\/p>\n<p>\t\t10. PROFILES OF MAJOR PRODUCERS<\/p>\n<p class=\"text-secondary fs-6\">The Largest Producers on The Market and Their Profiles<\/p>\n<p>                        11. COUNTRY PROFILES<\/p>\n<p class=\"text-secondary fs-6\">The Largest Markets And Their Profiles<\/p>\n<p>                        <a class=\"pe-2 fs-5 mb-2\" target=\"_blank\" href=\"https:\/\/www.indexbox.io\/licenses\/\" rel=\"nofollow noopener\">This Chapter is Available Only for the Professional Edition<\/a><br \/>\n                        PRO<\/p>\n<p>11.1<\/p>\n<p>United States<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.2<\/p>\n<p>China<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.3<\/p>\n<p>Japan<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.4<\/p>\n<p>Germany<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.5<\/p>\n<p>United Kingdom<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.6<\/p>\n<p>France<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.7<\/p>\n<p>Brazil<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.8<\/p>\n<p>Italy<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.9<\/p>\n<p>Russian Federation<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.10<\/p>\n<p>India<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.11<\/p>\n<p>Canada<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.12<\/p>\n<p>Australia<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.13<\/p>\n<p>Republic of Korea<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.14<\/p>\n<p>Spain<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.15<\/p>\n<p>Mexico<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.16<\/p>\n<p>Indonesia<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.17<\/p>\n<p>Netherlands<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.18<\/p>\n<p>Turkey<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.19<\/p>\n<p>Saudi Arabia<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.20<\/p>\n<p>Switzerland<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.21<\/p>\n<p>Sweden<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.22<\/p>\n<p>Nigeria<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.23<\/p>\n<p>Poland<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.24<\/p>\n<p>Belgium<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.25<\/p>\n<p>Argentina<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.26<\/p>\n<p>Norway<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.27<\/p>\n<p>Austria<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.28<\/p>\n<p>Thailand<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.29<\/p>\n<p>United Arab Emirates<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.30<\/p>\n<p>Colombia<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.31<\/p>\n<p>Denmark<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.32<\/p>\n<p>South Africa<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.33<\/p>\n<p>Malaysia<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.34<\/p>\n<p>Israel<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.35<\/p>\n<p>Singapore<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.36<\/p>\n<p>Egypt<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.37<\/p>\n<p>Philippines<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.38<\/p>\n<p>Finland<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.39<\/p>\n<p>Chile<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.40<\/p>\n<p>Ireland<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.41<\/p>\n<p>Pakistan<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.42<\/p>\n<p>Greece<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.43<\/p>\n<p>Portugal<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.44<\/p>\n<p>Kazakhstan<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.45<\/p>\n<p>Algeria<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.46<\/p>\n<p>Czech Republic<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.47<\/p>\n<p>Qatar<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.48<\/p>\n<p>Peru<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.49<\/p>\n<p>Romania<\/p>\n<p>Market SizeProductionImportsExports<\/p>\n<p>11.50<\/p>\n<p>Vietnam<\/p>\n<p>Market SizeProductionImportsExports<br \/>\n\t\tLIST OF TABLES<\/p>\n<p>\t\t\t\tKey Findings In 2025<br \/>\n\t\t\t\tMarket Volume, In Physical Terms: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tMarket Value: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tPer Capita Consumption, by Country, 2022\u20132025<br \/>\n\t\t\t\tProduction, In Physical Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tImports, In Physical Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tImports, In Value Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tImport Prices, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tExports, In Physical Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tExports, In Value Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tExport Prices, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<\/p>\n<p>\t\tLIST OF FIGURES<\/p>\n<p>\t\t\t\tMarket Volume, In Physical Terms: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tMarket Value: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tConsumption, by Country, 2025<br \/>\n\t\t\t\tMarket Volume Forecast to 2035<br \/>\n\t\t\t\tMarket Value Forecast to 2035<br \/>\n\t\t\t\tMarket Size and Growth, By Product<br \/>\n\t\t\t\tAverage Per Capita Consumption, By Product<br \/>\n\t\t\t\tExports and Growth, By Product<br \/>\n\t\t\t\tExport Prices and Growth, By Product<br \/>\n\t\t\t\tProduction Volume and Growth<br \/>\n\t\t\t\tExports and Growth<br \/>\n\t\t\t\tExport Prices and Growth<br \/>\n\t\t\t\tMarket Size and Growth<br \/>\n\t\t\t\tPer Capita Consumption<br \/>\n\t\t\t\tImports and Growth<br \/>\n\t\t\t\tImport Prices<br \/>\n\t\t\t\tProduction, In Physical Terms: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tProduction, In Value Terms: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tProduction, by Country, 2025<br \/>\n\t\t\t\tProduction, In Physical Terms, by Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tImports, In Physical Terms: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tImports, In Value Terms: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tImports, In Physical Terms, By Country, 2025<br \/>\n\t\t\t\tImports, In Physical Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tImports, In Value Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tImport Prices, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tExports, In Physical Terms: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tExports, In Value Terms: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tExports, In Physical Terms, By Country, 2025<br \/>\n\t\t\t\tExports, In Physical Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tExports, In Value Terms, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<br \/>\n\t\t\t\tExport Prices, By Country: Historical Data (2012\u20132025) and Forecast (2026\u20132035)<\/p>\n","protected":false},"excerpt":{"rendered":"May 17, 2026 Private companies in the biotechnology sector are increasingly entering public markets through initial public offerings,&hellip;\n","protected":false},"author":2,"featured_media":84302,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[276,1166,12876,44927,44928,6613,272,15446,44929,277],"class_list":["post-84301","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-eli-lilly","tag-glp-1-drugs","tag-ipos","tag-kailera-therapeutics","tag-klra","tag-netflix","tag-novo-nordisk","tag-nvidia","tag-ribupatide","tag-weight-loss-drugs"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/116588457716097600","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/84301","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=84301"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/84301\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/84302"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=84301"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=84301"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=84301"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}